Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Stephen James Luen, Roberto Salgado, Maria Vittoria Dieci, Andrea Vingiani, Giuseppe Curigliano, Rebekah Hubbard, Carlos Castaneda Altamirano, Joselyn Sanchez, Timothy D'Alfonso, Esther Cheng, Miluska Castillo Garcia, Sylvia Adams, Fahad Ahmed, David L. Rimm, Sandra Demaria, William Fraser Symmans, Stefan Michiels, Sherene Loi
Institutions: Peter MacCallum Cancer Centre, Institut Jules Bordet, University of Padua, Istituto Oncologico Veneto, European Institute of Oncology, University of Milan, The University of Texas MD Anderson Cancer Center, Instituto Nacional de Enfermedades Neoplásicas, Cornell University, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Yale University, Weill Cornell Medicine, Institut Gustave Roussy
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2806229069